Market Indices
Sector Heatmap
STOK — Stoke Therapeutics, Inc. Common Stock
NasdaqStoke Therapeutics, Inc. Common Stock
- O
- 24.04
- H
- 24.29
- L
- 23.65
- V
- 661.14K
STOK — Latest News & Headlines
20 StoriesStoke Therapeutics (NASDAQ:STOK) Stock: Insider Jonathan Allan Sells 627 Shares - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) Stock: Insider Jonathan Allan Sells 627 Shares MarketBeat
Officer Jonathan D. Allan proposes selling 627 shares of Stoke Therapeutics (STOK). - Stock Titan
Officer Jonathan D. Allan proposes selling 627 shares of Stoke Therapeutics (STOK). Stock Titan
Alector, Inc. (ALEC) Stock Price, News, Quote & History - Yahoo Finance
Alector, Inc. (ALEC) Stock Price, News, Quote & History Yahoo Finance
(STOK) Risk Channels and Responsive Allocation - Stock Traders Daily
(STOK) Risk Channels and Responsive Allocation Stock Traders Daily
Stoke Therapeutics (STOK) Insider Sale: General Counsel & Corp S - GuruFocus
Stoke Therapeutics (STOK) Insider Sale: General Counsel & Corp S GuruFocus
Stoke Therapeutics (STOK) Could Be 46% Below Fair Value As Clinical Catalysts Build - Simply Wall Street
Stoke Therapeutics (STOK) Could Be 46% Below Fair Value As Clinical Catalysts Build Simply Wall Street
BVF Partners Reveals 5.6% Ownership Stake in Stoke Therapeutics Inc. (NASDAQ:STOK) - Kalkine Media
BVF Partners Reveals 5.6% Ownership Stake in Stoke Therapeutics Inc. (NASDAQ:STOK) Kalkine Media
Stoke Therapeutics details Dravet cognition analysis after FDA meeting - Mugglehead Investment Magazine
Stoke Therapeutics details Dravet cognition analysis after FDA meeting Mugglehead Investment Magazine
Stoke Therapeutics (NASDAQ:STOK) Insider Sells 1,051 Shares of Stock - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) Insider Sells 1,051 Shares of Stock MarketBeat
At $26.33 a share, Jonathan Allan sells 627 shares of Stoke Therapeutics (STOK). - Stock Titan
At $26.33 a share, Jonathan Allan sells 627 shares of Stoke Therapeutics (STOK). Stock Titan
ServiceNow's AI contracts top $1B but stock lags; model sees 78% upside by 2028 despite current skepticism. - Pluang
ServiceNow's AI contracts top $1B but stock lags; model sees 78% upside by 2028 despite current skepticism. Pluang
Stoke Therapeutics (NASDAQ:STOK) Shares Down 5.9% - What's Next? - MarketBeat
Stoke Therapeutics (NASDAQ:STOK) Shares Down 5.9% - What's Next? MarketBeat
Under a trading plan, Stoke Therapeutics (STOK) medical chief sells 1,051 shares. - Stock Titan
Under a trading plan, Stoke Therapeutics (STOK) medical chief sells 1,051 shares. Stock Titan
Scandium Canada Ltd. (SCD.V) Stock Price, News, Quote & History - Yahoo! Finance Canada
Scandium Canada Ltd. (SCD.V) Stock Price, News, Quote & History Yahoo! Finance Canada
A passive stake at Stoke Therapeutics (STOK) includes 76,938 shares in a managed account. - Stock Titan
A passive stake at Stoke Therapeutics (STOK) includes 76,938 shares in a managed account. Stock Titan
STOK261016P00030000 interactive stock chart | STOK Oct 2026 30.000 put stock - Yahoo Finance Australia
STOK261016P00030000 interactive stock chart | STOK Oct 2026 30.000 put stock Yahoo Finance Australia
A Dravet medicine trial will measure changes in four areas of thinking and behavior - Stock Titan
A Dravet medicine trial will measure changes in four areas of thinking and behavior Stock Titan
Stoke Therapeutics aligns with FDA on zorevunersen NDA submission By Investing.com - Investing.com UK
Stoke Therapeutics aligns with FDA on zorevunersen NDA submission By Investing.com Investing.com UK
Form 4 Stoke Therapeutics Inc For: 26 September By Investing.com - Investing.com Australia
Form 4 Stoke Therapeutics Inc For: 26 September By Investing.com Investing.com Australia
AST SpaceMobile COO sells 12,000 shares worth $707K after 47% gain in one year - Pluang
AST SpaceMobile COO sells 12,000 shares worth $707K after 47% gain in one year Pluang